Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis

[51] Xue Y(2003)Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results Radiology 228 193-380

[52] Duan Q(2009)Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence J Neurol 256 878-2090

[53] Ma JH(2011)Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling Magn Reson Imaging 29 993-376

[54] Kim HS(2014)Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases Clin Oncol (R Coll Radiol) 26 704-2255

[55] Rim NJ(2009)Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis Eur J Radiol 72 370-88

[56] Kim SH(2014)Utility of intravoxel incoherent motion MR imaging for distinguishing recurrent metastatic tumor from treatment effect following gamma knife radiosurgery: initial experience AJNR Am J Neuroradiol 35 2082-287

[57] Cho KG(2015)Which is the best advanced MR imaging protocol for predicting recurrent metastatic brain tumor following gamma-knife radiosurgery: focused on perfusion method Neuroradiology 57 367-433

[58] Mouthuy N(2015)Diagnostic Accuracy of PET, SPECT, and arterial spin-labeling in differentiating tumor recurrence from necrosis in cerebral metastasis after stereotactic radiosurgery AJNR Am J Neuroradiol 36 2250-337

[59] Cosnard G(2010)Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery J Neurooncol 99 81-1577

[60] Abarca-Quinones J(2004)Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results Invest Radiol 39 277-761

[51] Xue Y(2003)Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results Radiology 228 193-380

[52] Duan Q(2009)Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence J Neurol 256 878-2090

[53] Ma JH(2011)Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling Magn Reson Imaging 29 993-376

[54] Kim HS(2014)Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases Clin Oncol (R Coll Radiol) 26 704-2255

[55] Rim NJ(2009)Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis Eur J Radiol 72 370-88

[56] Kim SH(2014)Utility of intravoxel incoherent motion MR imaging for distinguishing recurrent metastatic tumor from treatment effect following gamma knife radiosurgery: initial experience AJNR Am J Neuroradiol 35 2082-287

[57] Cho KG(2015)Which is the best advanced MR imaging protocol for predicting recurrent metastatic brain tumor following gamma-knife radiosurgery: focused on perfusion method Neuroradiology 57 367-433

[58] Mouthuy N(2015)Diagnostic Accuracy of PET, SPECT, and arterial spin-labeling in differentiating tumor recurrence from necrosis in cerebral metastasis after stereotactic radiosurgery AJNR Am J Neuroradiol 36 2250-337

[59] Cosnard G(2010)Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery J Neurooncol 99 81-1577

[60] Abarca-Quinones J(2004)Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results Invest Radiol 39 277-761